Ifosfamide/Etoposide Alternating With High-Dose Methotrexate: Evaluation of a Chemotherapy Regimen for Poor-Risk Osteosarcoma
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6690187
Full Text
Open PDFAbstract
Available in full text
Date
February 12, 1999
Authors
Publisher
Springer Science and Business Media LLC